Erprobung von Hilfsmitteln bei infantiler Cerebralparese mit der Bewegungs- und Ganganalyse Überblick Wegen meiner Tätigkeit am Spastiker-Zentrum München befasst sich mein beruflicher Alltag hauptsächlich mit der infantilen Zerebralparese und anderen neuroorthopädischen Erkrankungen. Zunächst werde ich einen aktuellen Überblick über die Zerebralparese und die Spastik geben und
- A |
J |K |
U |V |
Ahrmm.orgOctober 9, 2012
Colleague , your member number is . Please use this number when registering for
any AHRMM event or program.
October 25: Harnessing
Data Normalization to
Drive Product Savings
October 31: A CMO
Achieving Supply Chain
Gain valuable insight into thephysicians’ perspective of 1. Happy 2012 National Healthcare Resource & Materials Management
Discover new collaborationstrategies. Model/role playphysician engagement dialogfor use in your facility.
This week, AHRMM celebrates materials managers and healthcare supply chain professionals aroundthe country for their significant contributions to the healthcare field and the unyielding commitment topatient safety.
http://www.ahrmm.org/ahrmm/members_only/news/ahrmm_enews/archive/2012/MNU_10092012.htm[12/13/2012 4:35:14 PM]
These members of the healthcare family work behind the scenes, and their contributions too often go
unrecognized and unnoticed. Let’s take this week as an opportunity to the supply chain profession and to salute the outstanding accomplishments of its members.
In celebration of the Week),
AHRMM invited its members and non-members to submit a creative video, two minutes or less, from
their supply chain department depicting the amazing work the supply chain champions do every day.
We wanted this year’s theme to be heard loud and clear: Resource & Materials Management:
Champions of Patient Safety, Quality & Efficiency!
We are pleased to announce that the winner of the 2012 MM Week Video Contest
is “Angels in Supplies” video submitted by Melanie Bestland, Materials Director,
Materials Management at Lakewood Health System in Staples, Minnesota. Thank
you to the following individuals who worked on this winning video and helped to educate peers,
healthcare community, and the public on ways supply chain champions improve supply chain
efficiency and quality:
Click on the image below to watch the winning video:
2. AHRMM13 Call for Presentations Closes This Friday
Time is running out to apply to become a speaker at July 28-31, inSan Diego, California. All abstract proposals are due to AHRMM no later than Friday, October 12,2012.
AHRMM is looking for seasoned speakers offering dynamic, informative sessions in the followingareas within the healthcare supply chain field: Clinical Resource Management (CRM)Finance,Logistics,Professional DevelopmentProcurement,Evidence Based Management,Strategic PlanningTechnology Solutions Find more information about the AHRMM13 Call for Presentations and submit your application via http://www.ahrmm.org/ahrmm/members_only/news/ahrmm_enews/archive/2012/MNU_10092012.htm[12/13/2012 4:35:14 PM] 3. AHRMM Launches New Online Course: Yawn to Yowza - Making
Value Analysis Work
Most Value Analysis (VA) programs don't work. VA committee members typically yawn, roll their eyes,
and play with their blackberries while enduring yet another ineffective meeting. It doesn't have to be
this way. Value Analysis can and should be a vital, integral part of any organization's operations,
particularly when dealing with clinical and physician preference items.
In this informative and stimulating online course, you will learn what Value Analysis truly is - and what it
isn't. You will learn the history of Value Analysis, and review the six key ingredients of Value Analysis
success. Focusing on an evidence-based, multidisciplinary process driven from the top, you will review
the five-step VA methodology you can use to re-create and revitalize your Value Analysis program to
reach its full potential.
By the end of this course, you will learn to:
Define Value AnalysisDiscover why Value Analysis Programs FailDetermine how Value Analysis Contributes to Bottom Line SavingsList seven Value Analysis Critical Success FactorsIdentify Best Practice Value Analysis StructureDiscuss the Value Analysis MethodologyName the Value Analysis StepsDevelop a Value Analysis Communication Plan Speaker: Timothy Glennon, RN, MSN, CMRP, Vice President, Clinical Services, Greater New York
Hospital Association, Staten Island, NY
CEUs: You may earn 1.0 Contact Hour or 0.1 Continuing Education Units.
Cost: $79 – AHRMM Members; $99 – AHRMM Non-members
4. An Affiliated Chapter of AHRMM to Host Free GLN Implementation
On Monday, October 22, the Western States Healthcare Materials Management Association, an
affiliated Chapter of AHRMM, will host a complimentary GLN Implementation workshop with Scott
Dwyer, Item Master Manager, Supply Chain Management of The Cleveland Clinic, and Barb Zenner,
Senior Project Manager from Baxter. The session will be held at the Franciscan Education and Support
Center in Tacoma, WA.
Another complimentary session is scheduled for Tuesday, November 13, at the Longaberger
Alumni House in Columbus, OH. It will be presented by Rosalind Parkinson, Chief Supply Chain
Officer, and Becky Walkinshaw, Program Manager, Purchasing, both from The Wexner Medical Center
at Ohio State University, Columbus, OH; and John Terwilliger, Senior Business Systems Consultant,
Global Standards and Serialization, Abbott Labs.
Both sessions, co-sponsored by AHRMM, GS1 Healthcare US, HSCA, and SMI and will take place
from 9:30 am to 2:30 pm on both days to review successful GLN transition methods and practices and
earn 4.5 Contact Hours toward CMRP Certification or .45 Continuing Education Units for each
session. Visit for the workshop agenda and to register.
5. Term of the Week
Patient-Centered Medical Home (PCMH) reduced mortality rates and improved outcomes in
http://www.ahrmm.org/ahrmm/members_only/news/ahrmm_enews/archive/2012/MNU_10092012.htm[12/13/2012 4:35:14 PM] diabetes patients, according to a study published in The Joint Commission Journal on Quality andPatient Safety. Based on the chronic-care model, the PCMH focuses on care coordination betweenmultiple payers to meet patient needs.
Take a moment to peruse AHRMM’s. Do you have a term to suggestto make this a more robust and valuable resource? If so, . We’ll provide the definition if youprovide the term! INDUSTRY NEWS
6. We Care. We Vote. Only 29 Days Left till Elections. Make an Impact
Now is the time to contact your legislators and candidates for office to voice your concerns about thefuture of healthcare and advocate on behalf of your organization and community.
The hospital field consists of more than 5 million members. Let’s make sure that every one of themparticipates in this critical election and is a part of the debate over the national debt.
Registration deadlines and early voting availability vary by state. Find your state’s deadlines and otherhelpful resources at 7. Free Independent Study Course: Implementing Critical
Infrastructure Protection Programs IS-921 is Now Available
The Department of Homeland Security Office of Infrastructure Protection recently released a new
independent study course titled Implementing Critical Infrastructure Protection Programs
(IS-921) that is available through the Federal Emergency Management Agency (FEMA) Emergency
The training is designed to provide the tools and techniques needed by individuals with Critical
Infrastructure Protection responsibilities for both government and private sector organizations at the
local, state, regional, and federal levels. The content covers a range of topics including: forming
partnerships, sharing information, managing risk, and ensuring continuous improvement for critical
infrastructure protection and resilience programs.
The three-hour training course Implementing Critical Infrastructure Programs (IS 921) is available free
of charge. You may earn 0.3 CEUs toward CMRP Re-Certification (Note: CEUs issued by FEMA. To
receive CEUs, submit a supporting documentation such as a Certificate of Attendance/Completion, or
an agenda and a registration receipt).
To read more about this course visit: To take the course.
8. FDA Asks for Voluntary Recall of Popular Generic Antidepressant
The FDA's reversal of its approval of a generic equivalent of the popular antidepressant Wellbutrin XL300 ends a five-year saga that began with consumer complaints and a crusade by Joe Graedon, thecofounder of the consumer advocacy group the People's Pharmacy.
In 2007, Graedon began receiving disturbing complaints on his website from patients who had beentaking the 300 mg dose of Wellbutrin and had recently switched over to the generic equivalentBudeprion XL 300. Budeprion products are sold by Teva Pharmaceuticals and made by ImpaxLaboratories, both headquartered in Philadelphia.
http://www.ahrmm.org/ahrmm/members_only/news/ahrmm_enews/archive/2012/MNU_10092012.htm[12/13/2012 4:35:14 PM] "People were saying, 'I've been on Wellbutrin for several years and things were fine and dandy, butonce I was switched I started experiencing headaches, anxiety, depression, and sleeplessness'," hesaid. "People who had never been suicidal were all of a sudden reporting suicidal thoughts."At first Graedon said he was skeptical. But after he had received a few dozen messages, he decidedto write about it in his syndicated newspaper column. That's when the floodgates opened: Soon morethan a thousand messages poured into the People's Pharmacy website describing the samesymptoms, in intimate detail.
Alarmed, Graedon contacted Consumer Lab, an independent testing group based in White Plains, NY,and asked them to evaluate the 300 mg dose of the generic pill. The findings of the Consumer Labtests suggested that while the active ingredient in the generic Budeprion XL 300 mg and brand-nameWellbutrin XL 300 mg products was identical, the rate at which it was released differed.
"In the first two hours of a dissolution test, we found Budeprion released 34 percent of the drug, whileWellbutrin released 8 percent. At four hours, the Teva product released nearly half of its ingredients,while original Wellbutrin released 25 percent. The generic did not act like a once-a-day formula butmore like an immediate release formula," Dr. Todd Cooperman, Consumer Lab's president, stated.
Cooperman said the problems arose because of an unusual circumstance where the patent on thedrug itself had expired, making it available in generic form, but the time-release mechanism used in theoriginal did not. The original pill has a membrane so that the drug seeps out over time. The Teva pillsimply breaks apart.
Consumer Labs and the People's Pharmacy took their concerns to the FDA and requested informationon the human drug trials that companies are typically required to submit for drug approval. After whatGraedon described as "a lot of back and forth," the FDA revealed that the 300 mg product had neverundergone bioequivalence testing even though this is typical agency protocol. Instead, their approvalwas based on tests of a 150 mg version of the drug.
Graedon said although it's well understood that different dosages of drugs frequently don't have thesame results and can produce varied side effects, the agency stood by its approval of the 300 mgdose of the generic. However, they asked Teva to voluntarily perform its own trials involving peoplewho had reported problems. Citing difficulty recruiting subjects, the company never performed thetests.
Then in 2010, the FDA took the unusual step of conducting its own independent trial of 24 subjects. Itfound that the maximum concentration of Budeprion XL 300 in the blood reached only 75 percent ofthe amount Wellbutrin XL 300 released.
When results of the trials became available recently, the agency sent both Teva and Impaxcommunications asking them to voluntarily withdraw the drug from the market. Both companies havecomplied with the request.
FDA spokesperson Sandy Walsh stressed that this is not a recall, which is typically done when a drugis unsafe.
The agency estimates that only about 2 percent of people taking a 300 mg dose of a generic versionof the antidepressant take the Teva pill. They have asked other manufacturers of generic 300 mg doseversions of Wellbutrin to conduct their own studies and submit their data no later than March 2013.
But is this voluntary recall just the tip of the iceberg? Does it mean there could be other generics inwide use that are either unsafe or ineffective? Dr. Harold Koenig, associate professor of psychiatryand medicine at Duke University said he doesn't believe this is the case. Visit thearticle.
Source: HPN Daily Update - October 9, 2012 http://www.ahrmm.org/ahrmm/members_only/news/ahrmm_enews/archive/2012/MNU_10092012.htm[12/13/2012 4:35:14 PM] 9. CDC Issues Update on Contaminated Steroid Drug
About 75 in 23 states received potentially contaminated epidural steroidmedication prepared by New England Compounding Center in Framingham, MA, according to aCenters for Disease Control and Prevention. As of October 8, 105 cases of fungal meningitis,including eight deaths and some strokes, have been associated with three lots of the medication thatwere recalled on Sept. 26. Physicians should contact patients who received injections from the lots tosee if they have any symptoms, inform their state health department of any patients undergoingevaluation for infection, and report any suspected adverse events to FDA's CDCsaid. As a precaution, NECC the recall October 6 to include all compounded productsdistributed from the facility. There is currently no evidence of infection related to the other products. Formore information, visit Source: AHA News Now - October 8, 2012 10. Hospitals Reminded to Complete RACTrac Survey
The AHA encourages all hospitals to submit data to its quarterly RACTrac survey by October 15. Thefree web-based survey helps AHA gauge the impact of Medicare's Recovery Audit Contractor programon hospitals and advocate for needed changes. To register for the survey or for technical assistance,participants should contact RACTrac support at (888) 722-8712 or.
For more on the survey, including the latest results, visit Source: AHA News Now - October 4, 2012 11. Bellwether League Honors Supply Chain Veterans at Annual
Bellwether League Inc.'s 5th Annual Honoree Induction Dinner event on October 2 paid tribute to 10
honorees of the Bellwether Class of 2012.
The 10-member Board of Directors of the healthcare supply chain leaders' hall of fame announced the
10 honorees this past summer. The following professionals comprised the Bellwether Class of 2012:
John H. Clarke, Paul V. Farrell, Max Goodloe Sr., Roberta Graham, R.N., George O. Hansen, James
L. Hersma, Thomas W. Hughes, Carl L. Manley, Raymond Seigfried and Robert A. Simpson.
Bellwether Class of 2012
Back row (left to right): George O. Hansen, Thomas W. Hughes, Peter Farrell (son of Honoree Paul V.
Farrell), Robert A. Simpson, and James L. Hersma.
Front row (left to right): Carl L. Manley, Mary Farrell (daughter of Honoree Paul V. Farrell), Roberta Graham,
R.N., John H. Clarke, and Raymond Seigfried.
Not pictured: Max H. Goodloe Sr.
Bellwether League Inc. selected these bellwethers for their achievements and contributions in the
http://www.ahrmm.org/ahrmm/members_only/news/ahrmm_enews/archive/2012/MNU_10092012.htm[12/13/2012 4:35:14 PM] delivery of quality care through efficient and innovative supply chain operations. They representcreative thinkers who take the initiative, expand the boundaries of what's possible, and perform in away that improves and promotes the profession of supply chain management among hospitals, grouppurchasing organizations (GPOs), manufacturers and distributors, consulting firms, educationalinstitutions, and media properties.
For the view September/October 2012 digital issue ofAHRMM’s Supply Chain Strategies & Solutions newsletter.
Source: HPN Daily Update - October 4, 2012 12. Statement from HHS Secretary Kathleen Sebelius on Breast
Cancer Awareness Month
In October, during National Breast Cancer Awareness Month, we remember those who have lost theirlives to breast cancer, and those who are battling it now, by recommitting ourselves to their fight andspreading the word of the importance of prevention and early detection.
Despite significant advances in treatment and prevention, breast cancer remains the second leadingcause of cancer death for women in the United States. However, because of the Affordable Care Act,it's a new day for women's health and the fight against breast cancer.
We know that the chance of successful treatment is highest when breast cancer is detected early.
While not a perfect tool, mammogram screenings are key to early detection. But budgets are tight, andeven moderate copays can deter many women from getting those important screenings.
Because of the Affordable Care Act many private health plans and Medicare now cover mammogramsand certain other preventive services with no copays or other out-of-pocket costs. This means thatwomen can get the potentially life-saving services they need to detect breast cancer before it spreads,without worrying how a copay would affect their family budget. Last year, more than 6 million womenwith Medicare got a free mammogram.
Under the healthcare law, other services to help prevent breast cancer are also covered, such as awell-woman visit - at no additional cost- so women have the opportunity to talk to their doctor abouttheir healthcare needs, their personal risk for breast cancer, and their best options to reduce their risk.
The Affordable Care Act gives women, not insurance companies or the government, control over theirhealthcare.
Women also have new rights and protections under the law against insurance company abuse. Ifdiagnosed with breast cancer or another illness, women cannot have their coverage taken away whenthey need it the most simply because of a mistake made on paperwork. And beginning in 2014, it willbe illegal for insurers to discriminate against anyone with a pre-existing condition, such as breastcancer.
The health reform law is also helping women who are going through costly breast cancer treatment bypreventing insurance companies from imposing lifetime dollar caps on coverage. This means thatwomen fighting breast cancer can focus on their health, their families, and living their lives, and notworrying that their insurance will run out while they still need treatment.
We have made substantial progress in reducing the burden and toll of breast cancer on Americanwomen and their families. Initiatives under the Affordable Care Act, along with ongoing research, aremaking real differences in the lives of American women and their families. Visit Source: HPN Daily Update - October 3, 2012 FEATURED PRODUCT
http://www.ahrmm.org/ahrmm/members_only/news/ahrmm_enews/archive/2012/MNU_10092012.htm[12/13/2012 4:35:14 PM] 13. Primer Applying the Principles of Supply Chain Management in the
Healthcare Provider Sector
An invaluable guide for those who have come to a new position as a supply chain leader within aprovider organization from another industry or even right out of school, but also for senior executiveswho take on executive oversight of a provider supply chain for the first time in their career, whether ornot they are veterans of the healthcare industry.
It covers most of the elements of the healthcare supply chain providing a firm foundation on which tobuild a successful career in the field. The Association for Healthcare Resource & Materials Management (AHRMM) of the American Hospital Association is theleading national association for executives in the healthcare materials management profession. Founded in 1951,AHRMM prepares its more than 4,200 members to contribute to the field and advance in the profession throughnetworking, education, recognition, and advocacy. AHRMM continues its commitment to keep members ahead of thelearning curve by providing information and resources to not only assist them in their current positions, but also toprepare them for upcoming challenges and opportunities. Please email us at call (312) 422-3840 ifyou need additional information on these stories or any of AHRMM's products and services. This email is intended as an exclusive benefit for AHRMM member, Colleague . If you have any questions or are not
the intended recipient of this email please contact AHRMM directly at
AHRMM is dedicated to bringing important healthcare news to its members. If you prefer to receive a text-only version ofthis e-newsletter, please write to . To unsubscribe from the AHRMM eNews, please send an email to [email protected] with "unsubscribe AHRMM eNews" inthe subject line. Please do not distribute this email without written permission from AHRMM. American Hospital Association | 155 North Wacker Drive, Suite 400 | Chicago, IL 60606
http://www.ahrmm.org/ahrmm/members_only/news/ahrmm_enews/archive/2012/MNU_10092012.htm[12/13/2012 4:35:14 PM]
CANDIDA INFECTIONS IN THE NEONATE Summary Colonization with Candida is common in newborns. Candida albicans is the most prevalent species but others eg C. parapsilosis are also seen. Candidal infections range from relatively benign oral and cutaneous candidiasis to severe and fatal congenital and systemic infection. Acquisition of candida may occur in utero by the ascending route from